Paul Finnegan
Chief Executive Officer at Angiocrine Bioscience, Inc.
- Role
- Chief Executive Officer at Angiocrine Bioscience, Inc
- Location
- San Diego, CA, US
- LinkedIn followers
- 500 followers
About Paul Finnegan
General manager/ senior executive with deep experience spanning commercial (including BD), operations, and clinical development of innovative medicines. Broad therapeutic coverage: rare disease therapeutics; anti-inflammatory and pain therapeutics; autoimmune, cardiovascular and hemato-oncology therapeutics. Special interest in biologics and innovative delivery systems.Board experience in both public and private biotechnology companies, including chairing board committees. Consulted for multiple biotechnology, pharmaceutical and medical devices companies involving commercialization (especially international), business development and clinical development issues, usually interfacing with senior management clients; mainly involving development/commercialization of new, innovative products, international expansion, and/or due diligence for in-licensing and/or M&A.Additionally, spent several years as portfolio CEO/ EIR, involved in developing venture-funded start-up and emerging biotech companies; worked closely with venture captial and private equity. Past senior level roles in operations, business development, clinical development, and medical affairs; worked with companies from virtuals funded by venture/private equity to larger global entities such as Alexion, Pharmacia, and Searle/ Monsanto. Formal training in Medicine (MD, CM, FRCPC) and Business (MBA in Finance, Strategy and Marketing).Specialties: General management/ operations of start-up/ emerging/ virtual biotechnology companies; functional experience in pharma/biotech strategic marketing & branding (US & International); strategic planning & corporate development; business development (alliances & licensing); finance/ valuations; strategic pipeline (drug and clinical) development in therapeutic areas of hematology/oncology, cardiovascular, pain and inflammation; patient advocacy; public affairs
Experience
Chief Executive Officer
May 2015 — Present
Education
McGill University
MD, CM, Medicine, Surgery
1981 — 1985
The University of Chicago Booth School of Business
MBA, Finance, Strategy
1996 — 1998
Skills
- Pharmaceutical Sales
- Life Sciences
- Biotechnology
- Medical Affairs
- Medical Devices
- Therapeutic Areas
- Protein Chemistry
- Cell
- Drug Development
- Biopharmaceuticals
- Strategy
- Pharmaceutical Industry
- Lifesciences
- CRO
- Commercialization
- Clinical Trials
- Pharmaceutics
- Clinical Development
- Business Development
- Neurology
- Start-Ups
- Oncology
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.